Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nice! Big things coming, be patient all
Here is the link to Intellicell's Executive Summary:
http://proactivecapital.com/wp-content/uploads/2013/02/imtellicellfactsheet.pdf
SVF Opportunity
IntelliCell’s regenerative solutions are ideally positioned to restore function by enabling the body to repair damaged, aging, and diseased cells, tissues, and organs, across major disease states and conditions.
MAJOR DISEASES
Orthopedics
ANTI-AGING
Lines and Wrinkles
Osteoarthritis
Type II Diabete
Parkinson’s and Wrinkles
Hair Loss
Parkinson s Disease
Breast Augmentation
Alzheimer’s
Cerebral Palsy
Scars (acne and other)
Face & Hands Volume Filling
Autism
Multiple Sclerosis
Hypertension
Stroke
Burns
Orthopedics: Over 1 Million Hip and knee replacements, 600,000
back procedures performed annually in the U.S. where SVFs could
potentially mitigate the need for surgery.
Sports Medicine: A $1.3B addressable market and a key corporate
focus with meaningful partnerships already secured.
b]Periodontal Disease: A $6B addressable market; IntelliCell has
recently completed case studies using SVFs in the treatment of gum
recession showing no need for grafting
I_Glow, I thought this would be a good thing since on June 27th you had the following quote:Do you think they are just trying to clean house?
"It seems that LL Bradford has a little pump and dump dirt on their hands - it seems they have "audited" several scam companies in the past that have been promoted.
I am just starting on the list but here are a couple.
SNWT, GSPT and it looks like they audited the infamous Hall of Fame pump and Dump AEGY and it now appears that Robert Hipple has ties to LL Bradford.
WOW, the scam has another layer peeled away - this is going to be fun"
IG
JLE86,
I think the "delivery system" is the method of delivering the larger doses of medicine. But, I hope you are 100% right about news soon.
This will follow $KTO hopefully next week.
AEGY Money to be made
Would be nice to here he treated AP and RGIII too! That would light it up...
SVFC
I just hit ask for another 500k shares, will do the same after lunch again. Lets push through the 8's
I hear ya! Good luck to you.This will have it's time and it will be soon.
Nice..... Won't be long and they will be filing an 8K stating that VUK owns 9.99% of AEGY
Go get them shares
GLTA
Let's all follow what Koos does and take his loan payment back from BMSN in shares 60,000,000 to be exact, Are you a poster for Southridge?
Nice call! can't hardly stand that board with all the bashers though. If the bashers are out in full force you know their short! I ran out of ignores on that board. I have 1 milly and waiting for the slow rise to success. Think Nick is doing this right.
Go check out AEGY Pharmajanes.com it is NIIIIIIICCCCEEEEE!
I do believe they will merge at some point maybe even with Iequity when they list the new IPO. IMO
Fidelity! no problems at all
Being that I do not bash stocks but wish fellow traders good luck at all times, I do not believe I will be visited by the Karma bug!
BMSN is much bigger than some of our favorite posters
Why does this not surprise me at all?
Just hope we can all pick the right stocks to be in when this happens.
GLTA
Just sent my email off with at least 8 questions and will update board as I hear back.
Good things coming just need to be patient.
Seattle, love your whole attitude about this stock and more importantly the priority of family in prior posts!
SVFC
Thanks Caz! I will get them together and report out after response.
What are the new questions and Steven's email address? I will formulate a letter to him in the morning. I am not at work where I saved his email on my computer.
Thanks,
If the flippers are happy flipping 1,000,000 shares at a max of .0003 to make $300 bucks they will still do this in my opinion. I would prefer to stay long and not pay Cap Gains. So of the $300 they make they really only make $174 or whatever their tax bracket allows. Too much work for little pay.
SVFC was not a pumped penny stock at all. There were investors here daily waiting on the PR's which were exciting at the time. Some or a lot have been quiet just waiting for the issues to be resolved with IR. Intellicell has not released any of this as of yet because of the pending suit. When this is taken care of and again favorable you will see the passion for the Science to come back to this board.
IMHO.
Long on SVFC and hope everything turns out well this week.
So this explains why it takes a while for approval:
http://www.forbes.com/sites/matthewherper/2013/06/23/the-fdas-cancer-czar-says-he-cant-approve-new-drugs-fast-enough/
Quote from FDA's Cancer Czar:
It’s not if we’re going to approve them. It’s how fast we’re going to approve them.”
Really like the sounds of this Artice! Go BMSN
La Mesa's Regen BioPharma at Work on Breast Cancer Vaccine
Regan will conduct research using gene technology developed by Benitec Biopharma.
Posted by Jennifer Vigil (Editor) , August 13, 2013 at 12:00 PM
patch
Comment Recommend
A Regan researcher. The La Mesa company is involved in the search for a cure for breast cancer. Photo credit: ReganBioPharma.com
A Regan researcher. The La Mesa company is involved in the search for a cure for breast cancer. Photo credit: ReganBioPharma.com
Could a vaccine to fight breast cancer be developed in La Mesa?
At the very least La Mesa company Regen BioPharma could play a role, reports the San Diego Daily Transcript. Regen's logo includes the words “fast forwarding stem-cell medicine.”
Popular Stories
Issue: Will Letting Transgender Students Pick Restrooms Do…
Issue: Should Rep. Issa Concede Climate Change Is…
Women Robbed of Purses at Gunpoint on La Mesa Boulevard
Regen, a subsidiary of Bio-Matrix Scientific Group (OTC: BMSN), has a licensing agreement with Benitec Biopharma (ASX: BLT) for vaccines that can be developed using gene technology shaped by Benitec.
Ever worked in a laboratory? Help us decipher the technology they'll be using, according to the report: “the application of ddRNAi to silence indoleamine 2,3 - dioxygenase (IDO) in dendritic cells.”
Huh? Let's break it down a bit. IDO may cause immune suppression and is present when there is cancer. In preliminary work, Regan has shown that altering the cells with ddRNAi could make it more likely for use in the development of a vaccine to fight cancer.
According to a news release, Dr. David Koos, Regen's CEO, said, the work could lead to “an immune-based, non-toxic, cancer treatment initially targeting breast cancer."
The science behind the research has been examined in The Journal of Cancer.
Comment Recommend
Can that be a question you ask Dr. Koos? This would put a lot of bickering to rest. thanks PG
Our own Dr. Ichim:
http://www.translational-medicine.com/content/pdf/1479-5876-11-56.pdf
phase 2 results
WOW! Didn't even know they had revenues coming in and helping to fund larger projects through selling Instrumentation and cell banks.
This is the future! People better get on board or get left behind.
Just remember: Steve Jobs had more naysayers than supporters!
BMSN$$
Spot on Seattle! When this is resolved we bank! The technology is too good. Here is proof that stem cell technology is heating up!!
NEW YORK, Aug. 14, 2013 /PRNewswire/ -- The Tisch MS Research Center of New York announced today that it has received Investigational New Drug (IND) approval from the Food and Drug Administration (FDA) to commence a Phase 1 trial using autologous neural stem cells in the treatment of multiple sclerosis (MS). MS is a chronic human autoimmune disease of the central nervous system that leads to myelin damage and neurodegeneration and affects approximately 2.1 million people worldwide.
"To my knowledge, this is the first FDA-approved stem cell trial in the United States to investigate direct injection of stem cells into the cerebrospinal fluid of MS patients, and represents an exciting advance in MS research and treatment," said Dr. Saud A. Sadiq, Senior Research Scientist at Tisch MS Research Center of New York and the study's principal investigator.
The groundbreaking study will investigate a regenerative strategy using stem cells harvested from the patient's own bone marrow. These stem cells will be injected intrathecally (into the cerebrospinal fluid surrounding the spinal cord) in 20 participants who meet the inclusion criteria for the trial. This will be an open label safety and tolerability study. All study activities will be conducted at the Tisch MS Research Center and affiliated International Multiple Sclerosis Management Practice (IMSMP).
The clinical application of autologous neural progenitors in MS is the culmination of a decade of stem cell research conducted by a dedicated team of scientists headed by Dr. Sadiq and by Dr. Violaine Harris, Research Scientist at Tisch MS Research Center.
Preclinical testing found that the injection of these cells may decrease brain inflammation and promote myelin repair and/or neuroprotection. "This study exemplifies the Tisch MS Research Center's dedication to translational research and provides a hope that established disability may be reversed in MS," Dr. Sadiq noted.
Participants will undergo a single bone marrow collection procedure, from which mesenchymal stem cell-derived neural progenitor cells (MSC-NPs) will be isolated, expanded and tested prior to injection. Participants will receive three rounds of injections at three month intervals. Safety and efficacy parameters will be evaluated in all participants through regular follow-up visits.
For more information on this study visit: www.tischms.org
ABOUT TISCH MS RESEARCH CENTER OF NEW YORK
For over twenty years, Dr. Saud A. Sadiq has believed that combining excellence in clinical care with innovative research targeted at finding the cure for multiple sclerosis would set an exemplary standard in the treatment of MS patients. Today, the Tisch MS Research Center of New York embodies this new model of healthcare, in which your doctor is also your researcher. Dr. Sadiq helps those with MS by conducting cutting-edge, patient-based research to ensure unparalleled care. The close relationship of the non-profit research center and its affiliated clinical practice (International Multiple Sclerosis Management Practice) enables the testing of new MS treatments and accelerates the pace at which research discoveries move from lab bench to bedside. The Tisch MS Research Center of New York aims to identify the disease trigger, optimize treatments for patients, and repair the damage caused by multiple sclerosis.
OK, looks like this promotion is for SAFC not SVFC.
I believe he was named in the Ironridge filing this morning.
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=9455879
Guess we will wait and see if that was BS or truth! I would welcome this as well to jump start us through all of this drama lately!
GO SVFC
The stock they were discussing was SVFC! Sorry Cazual I do not have PM.
Was on another stock board of mine and low and behold I read the below message:
From RPH9878:
I also just got 3 email alerts about a biotech feature coming in the morning.
The stock they were discussing was : S@FC
Are we getting a promotion on Thursday????????
Why all of a sudden did we forget we have a expert litigator around securities?
Michael J. Hershman
Mr. Hershman is an internationally recognized expert on matters relating to transparency, accountability, governance, litigation and security. President and CEO of the Fairfax Group, a company he founded in 1983, that has been retained by governments, corporations, law firms and international financial institutions to assist on matters relating to the consult of senior-level officials and/or the entities with which they do business.
I believe Intellicell has the money in Escrow but wants to be sure they are paying the correct entity back through secured party. Will be done after today hopefully!
SVFC
DK, Could not agree more! About time we fight back for BMSN and our investment....
BMSN
I am with you Cash Devil! Buy when there is blood.....
Getting really exciting around here for those that can see through the BS. Can't wait for the plan to be executed so everyone will see this GEM for what it is!
BMSN
Been lurking for a few weeks with no posts but very happy with the DD on this company! Will be back in no time happier than ever.
Big turn of events coming.
SVFC
Fingers crossed! A shout out to PG! Thanks for keeping everyone informed with the sound DD.